The challenge of palmoplantar pustulosis therapy: Are Interleukin-23 inhibitors an option?

Poortinga, S; Balakirski, G; Kromer, C; Mössner, R; Schön, M P; Bieber, T; Wilsmann-Theis, D

Poortinga, S; Balakirski, G; Kromer, C; Mössner, R; Schön, M P; Bieber, T; Wilsmann-Theis, D.

Afiliación

Poortinga S; Department of Dermatology and Allergology, University Hospital of Bonn, Bonn, Germany.
Balakirski G; Department of Dermatology and Allergology, University Hospital of Bonn, Bonn, Germany.
Kromer C; Department of Dermatology, Allergology and Dermatosurgery, HELIOS University Hospital Wuppertal, University of Witten/Herdecke, Wuppertal, Germany.
Mössner R; Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany.
Schön MP; Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany.
Bieber T; Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany.
Wilsmann-Theis D; Lower Saxony Institute of Occupational Dermatology, University Medical Center Göttingen, Göttingen, Germany.

J Eur Acad Dermatol Venereol ; 35(12): e907-e911, 2021 Dec.

Article en En | MEDLINE | ID: mdl-34309915

Asunto(s)

Exantema; Psoriasis; Enfermedades Cutáneas Vesiculoampollosas; Enfermedad Crónica; Humanos; Interleucina-23; Psoriasis/tratamiento farmacológico

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Enfermedades Cutáneas Vesiculoampollosas / Exantema Límite: Humans Idioma: En Revista: J Eur Acad Dermatol Venereol Asunto de la revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Año: 2021 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google